vimarsana.com

Latest Breaking News On - Prnewswire immunic inc - Page 8 : vimarsana.com

Immunic, Inc to Participate in Upcoming Investor and Industry Conferences

Press release content from PR Newswire. The AP news staff was not involved in its creation.

United statesSan diegoComunidad autonoma de catalunaEdna kaplanPaula schwartzJessica breuWerner gladdinesDaniel vittExchange commissionClinical development operations of immunicRx communications groupClinical trial technologyPrnewswire immunic incImmunic incChief executive officerClinical trials europe

Immunic, Inc to Participate in Investor and Scientific Conferences in March

/PRNewswire/ Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies focused.

United statesBruxelles capitaleEdna kaplanPaula schwartzDuane nashJessica breuMeeting of the society for virologyDrug information associationRx communications groupPrnewswire immunic incExchange commissionAmerican academy of dermatologyImmunic incAnnual rothAnnual roth conferenceDana point

Immunic, Inc to Participate in Investor and Scientific Conferences in March

/PRNewswire/ Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies focused.

United statesBruxelles capitaleEdna kaplanPaula schwartzDuane nashJessica breuMeeting of the society for virologyDrug information associationRx communications groupPrnewswire immunic incExchange commissionAmerican academy of dermatologyImmunic incAnnual rothAnnual roth conferenceDana point

Immunic, Inc to Participate in Investor and Scientific Conferences in March

Press release content from PR Newswire. The AP news staff was not involved in its creation.

United statesBruxelles capitaleEdna kaplanPaula schwartzDuane nashJessica breuMeeting of the society for virologyDrug information associationRx communications groupPrnewswire immunic incExchange commissionAmerican academy of dermatologyImmunic incAnnual rothAnnual roth conferenceDana point

Immunic, Inc to Participate in Investor and Scientific Conferences in February

/PRNewswire/ Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at.

Edna kaplanPaula schwartzJessica breuEvelyn peelenDaniel vittExchange commissionColitis organizationRx communications groupPrnewswire immunic incImmunic incAegis capital corpAnnual global healthcareChief executive officerEuropean crohnSenior manager translational pharmacologySmall molecule

vimarsana © 2020. All Rights Reserved.